The agreement between Janssen and SPIMACO outlines a commitment to invest in technology transfer of pharmaceuticals within Saudi Arabia in a variety of therapeutic areas. The agreement relates to several innovative therapies which will accelerate the development of the country’s capabilities in the pharmaceutical sector, as well as address complex health needs of the nation.